<DOC>
	<DOC>NCT00139165</DOC>
	<brief_summary>The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)</brief_summary>
	<brief_title>Long-Term Treatment of Collagenous Colitis With Budesonide</brief_title>
	<detailed_description />
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis, Collagenous</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Histological criteria of Collagenous colitis Clinical activity (&gt; 3 stools/day) Treatment of Collagenous colitis within the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Collagenous colitis</keyword>
	<keyword>Budesonide treatment</keyword>
	<keyword>Diarrhea</keyword>
</DOC>